X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (212) 212
humans (208) 208
female (167) 167
middle aged (167) 167
hematology (164) 164
male (164) 164
adult (156) 156
aged (113) 113
life sciences (80) 80
transplantation (79) 79
treatment outcome (79) 79
oncology (76) 76
adolescent (70) 70
retrospective studies (68) 68
cancer (64) 64
young adult (56) 56
prognosis (54) 54
transplantation, homologous (54) 54
survival (53) 53
hematopoietic stem cell transplantation (49) 49
survival analysis (48) 48
immunology (47) 47
leukemia (47) 47
bone-marrow-transplantation (45) 45
chemotherapy (45) 45
abridged index medicus (43) 43
disease-free survival (43) 43
stem cells (43) 43
follow-up studies (42) 42
hematology, oncology and palliative medicine (41) 41
recurrence (40) 40
stem-cell transplantation (37) 37
remission induction (36) 36
transplantation conditioning - methods (36) 36
hematopoietic stem cells (34) 34
versus-host-disease (34) 34
therapy (33) 33
survival rate (31) 31
acute myeloid leukemia (30) 30
analysis (30) 30
acute myeloid-leukemia (29) 29
graft vs host disease - etiology (28) 28
hematopoietic stem cell transplantation - adverse effects (28) 28
hematopoietic stem cell transplantation - methods (28) 28
prospective studies (28) 28
antineoplastic combined chemotherapy protocols - therapeutic use (26) 26
bone marrow (26) 26
leukemia, myeloid, acute - therapy (26) 26
risk factors (26) 26
acute disease (24) 24
bone marrow transplantation (24) 24
care and treatment (24) 24
leukemia, myeloid, acute - mortality (24) 24
child (23) 23
france (22) 22
multivariate analysis (22) 22
relapse (22) 22
research (22) 22
transplantation conditioning (22) 22
transplantation, autologous (22) 22
mortality (21) 21
risk (21) 21
unrelated donors (21) 21
aged, 80 and over (19) 19
health aspects (19) 19
patients (19) 19
transplants & implants (19) 19
acute myelogenous leukemia (18) 18
child, preschool (18) 18
chronic myeloid-leukemia (18) 18
combined modality therapy (18) 18
incidence (18) 18
human health and pathology (17) 17
stem cell transplantation (17) 17
hemic and lymphatic diseases (16) 16
leukemia, myeloid, acute - drug therapy (16) 16
multiple myeloma (16) 16
outcomes (16) 16
trial (16) 16
antineoplastic agents - therapeutic use (15) 15
adults (14) 14
hematologic neoplasms - therapy (14) 14
imatinib mesylate (14) 14
medical research (14) 14
multiple myeloma - mortality (14) 14
recipients (14) 14
antineoplastic combined chemotherapy protocols - adverse effects (13) 13
chronic myelogenous leukemia (13) 13
cytarabine - administration & dosage (13) 13
graft (13) 13
kaplan-meier estimate (13) 13
leukemia, myelogenous, chronic, bcr-abl positive - drug therapy (13) 13
multiple myeloma - therapy (13) 13
time factors (13) 13
age factors (12) 12
antineoplastic combined chemotherapy protocols - administration & dosage (12) 12
chronic disease (12) 12
chronic myeloid leukemia (12) 12
drug administration schedule (12) 12
graft vs host disease - mortality (12) 12
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 05/2012, Volume 366, Issue 19, pp. 1782 - 1791
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2010, Volume 28, Issue 30, pp. 4621 - 4629
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 07/2012, Volume 30, Issue 20, pp. 2475 - 2482
Journal Article
Clinical Lymphoma, Myeloma and Leukemia, ISSN 2152-2650, 09/2018, Volume 18, pp. S19 - S20
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2010, Volume 28, Issue 5, pp. 808 - 814
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2012, Volume 30, Issue 36, pp. 4533 - 4540
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2013, Volume 31, Issue 28, pp. 3549 - 3549
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2007, Volume 357, Issue 24, pp. 2451 - 2460
Journal Article
British Journal of Haematology, ISSN 0007-1048, 02/2017, Volume 176, Issue 3, pp. 431 - 439
This study analysed the outcome of 267 patients with relapse/refractory acute myeloid leukaemia ( AML ) who received sequential chemotherapy including... 
sequential chemotherapy | reduced intensity conditioning | acute myeloid leukaemia | allogeneic haematopoietic stem cell transplantation | CYTOSINE-ARABINOSIDE | FREE SURVIVAL | BONE-MARROW-TRANSPLANTATION | 1ST COMPLETE REMISSION | MYELODYSPLASTIC SYNDROME | MATCHED UNRELATED DONORS | GRAFT-VERSUS-LEUKEMIA | HIGH-RISK | HLA-IDENTICAL SIBLINGS | HOST-DISEASE | HEMATOLOGY | Recurrence | Humans | Middle Aged | Male | Hematopoietic Stem Cell Transplantation - mortality | Leukemia, Myeloid, Acute - complications | Young Adult | Allografts | Hematopoietic Stem Cell Transplantation - adverse effects | Adult | Female | Surveys and Questionnaires | Retrospective Studies | Transplantation Conditioning - methods | Graft vs Host Disease - etiology | Leukemia, Myeloid, Acute - therapy | Antibodies - therapeutic use | Survival Rate | Treatment Outcome | Combined Modality Therapy | Leukemia, Myeloid, Acute - mortality | Antibodies - administration & dosage | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | T-Lymphocytes - immunology | Aged | Hematopoietic Stem Cell Transplantation - methods | Salvage Therapy - methods | Surveys | Viral antibodies | Chemotherapy | Relapse | Stem cells | Antibodies | Transplantation | T cells | Hematopoietic stem cells | Diseases | Cancer | Graft-versus-host reaction | Immunoglobulins | Transplants & implants | Leukemia | Stem cell transplantation | Transplants | Lymphocytes T | Multivariate analysis | Patients | Survival | Incidence | Cytarabine | Fludarabine | Donors | Conditioning | Index Medicus
Journal Article
Journal of Infection, ISSN 0163-4453, 2015, Volume 72, Issue 2, pp. 214 - 222
Journal Article